Expansion of dendritic cells derived from human CD34+ cells in static and continuous perfusion cultures

被引:0
作者
Soligo, D
Deliliers, GL
Quirici, N
Servida, F
Caneva, L
Lamorte, G
机构
[1] Osped Maggiore, IRCCS, Ctr Trapianti Midollo, I-20122 Milan, Italy
[2] Univ Milan, Fdn Matarelli, Milan, Italy
[3] Univ Milan, Osped Fatebenefratelli, Milan, Italy
关键词
cell cultures; cytokines; dendritic cells; ex vivo expansion; haemopoietic progenitor cells;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined the effects of different cytokine combinations and culture conditions on the expansion and modulation of cell surface antigens of CD34(+) derived dendritic cells (DCs), the most efficient antigen-presenting cells capable of stimulating resting T cells in the primary immune response. Cells with a dendritic morphology and expressing HLA-DR, CD1a, S100 and CD83 were maximally expanded under serum-free conditions with the addition of SCE GM-CSF TNF-alpha, TGF-beta and Flt-3 ligand (fold increase of CD1a(+) cells = 102 +/- 32 after 2 weeks of culture). CD34(+) cells were also grown under continuous flow conditions in an artificial capillary system; after 14d of culture, the expansion in the total cell number was lower than that of the static cultures (3.3 +/- 2 v 18.9 +/- 4) but the percentage of CD1a(+)/CD83(+)/CD80(+) cells was considerably higher, whereas the CD14(+) cells were significantly reduced (8.9 +/- 2 v 26 +/- 13). In continuous perfusion cultures. low levels of DC precursors and of LTC-IC were still present up to day 14. The DCs generated under now conditions stimulated the mixed leucocyte reaction (MLR) more than the cells grown in static cultures. By electron microscopy, cells grown in the continuous flow system showed an increased number of large cells with numerous dendritic processes and abundant multilamellar complexes. The cells expanded under these conditions were sorted on the basis of their light-scatter properties into two fractions: one containing a predominance of CD1a(+)/S100(+)/CD83(+)/CD80(+)/CD14(-) 'large cells' with great internal complexity (mature DCs); the second including 'small cells' either CD33(+)/CD14(+), CD33(+)/CD15(+) or CD33(+)/CD13(+/-)/CD14(-). The DCs generated and selected with this method are therefore particularly well suited for immunotherapeutic protocols.
引用
收藏
页码:352 / 363
页数:12
相关论文
共 40 条
[1]  
Aicher A, 1997, EXP HEMATOL, V25, P39
[2]  
ALZONA MT, 1966, BLOOD S1, V88, pA109
[3]  
BERNHARD H, 1995, CANCER RES, V55, P1099
[4]  
Bertolini F, 1996, CANCER RES, V56, P2566
[5]   GM-CSF AND TNF-ALPHA COOPERATE IN THE GENERATION OF DENDRITIC LANGERHANS CELLS [J].
CAUX, C ;
DEZUTTERDAMBUYANT, C ;
SCHMITT, D ;
BANCHEREAU, J .
NATURE, 1992, 360 (6401) :258-261
[6]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229
[7]   Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: Implications for studies on antigen-presenting cell function and immunotherapy [J].
Fearnley, DB ;
McLellan, AD ;
Mannering, SI ;
Hock, BD ;
Hart, DNJ .
BLOOD, 1997, 89 (10) :3708-3716
[8]   Dendritic cells in antitumor immune responses .2. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors [J].
Gabrilovich, DI ;
Nadaf, S ;
Corak, J ;
Berzofsky, JA ;
Carbone, DP .
CELLULAR IMMUNOLOGY, 1996, 170 (01) :111-119
[9]   Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors [J].
Garrigan, K ;
MoroniRawson, P ;
McMurray, C ;
Hermans, I ;
Abernethy, N ;
Watson, J ;
Ronchese, F .
BLOOD, 1996, 88 (09) :3508-3512
[10]  
Guardiola Ph., 1997, Experimental Hematology (Charlottesville), V25, P884